A critical resource available to Accelerator’s portfolio companies is access to the faculty and staff, core facilities and cutting-edge technology of the Institute for Systems Biology (ISB). The ISB’s world-class faculty and staff are important in the evaluation of potential investment opportunities, followed by creative and critical contributions to the development strategies of Accelerator Companies. Access to ISB’s core facilities enables Accelerator Companies to incorporate cutting-edge infrastructure and technologies into their scientific programs without the expensive capital outlays that would be needed to acquire, operate, and maintain these resources themselves. These resources also enable Accelerator and its portfolio companies to make data-driven development decisions.

Additionally, Accelerator’s investors and affiliates have both internal scientific experts as well as extensive networks of scientific consultants. For any technology, therapeutic class or disease category, this network can be tapped for relevant expertise that can help to evaluate and prioritize commercial opportunities.